SOADOR
FENC icon

State of Alaska Department of Revenue’s Fennec Pharmaceuticals FENC Stock Holding History

State of Alaska Department of Revenue’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70K Hold
6,570
– – ﹤0.01% 1864
2026
Q1 		$40K Buy
6,570
+5,000
+318% +$38.6K ﹤0.01% 1948
2025
Q4 		$12K Buy
+1,570
New +$12.9K ﹤0.01% 2175

Other funds holding FENC

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $339M AUM 120.53% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State of Alaska Department of Revenue's FENC Position: Q2 2026 in Review

State of Alaska Department of Revenue held its Fennec Pharmaceuticals (FENC) position steady in Q2 2026 at 6,570 shares worth $70K. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

State of Alaska Department of Revenue first reported a position in FENC in Q4 2025 and has held it in 3 quarters since. 50 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • State of Alaska Department of Revenue held 6,570 shares of Fennec Pharmaceuticals worth $70K as of Q2 2026.
  • State of Alaska Department of Revenue left its Fennec Pharmaceuticals share count unchanged in Q2 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1864 holding.
  • State of Alaska Department of Revenue first reported a position in Fennec Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 50 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.